Searched for
MOREPEN USFDA NOD
Sensex falls for 2nd day, dives 949 points; Rs 4.2 lakh crore investor wealth wiped outThe rapidly spreading Omicron variant is raising the risks in the market. A casualty of it was the cryptocurrency market over the weekend. ...- Morepen Labs zooms 8% on USFDA nod to market anti-allergy drugThe US FDA approval provides an imminent boost to Morepen’s export business as Fexofenadine is a well-established anti-allergy drug boastin...
- Morepen gets USFDA nod to market generic anti-allergy drugDrug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofin...
- The Week That Was in 10 Stocks: Pharma shares on a tear; IDBI, IndusInd Bank rallyA second stimulus package India is poised to announce in coming days will be worth around Rs 1 lakh crore.
- Morepen Labs gets USFDA nod for asthma drugMorepen is the market leader for Montelukast in India with over 50 per cent market share, supplying to almost all major finished dosage man...
Load More